| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.4B | $14.9B | $17.4B | $17.2B | $14.6B | $10.0B | $9.7B | $11.1B |
| Cost of Revenue | $9.5B | $7.9B | $9.7B | $9.4B | $7.8B | $5.4B | $5.3B | $5.9B |
| Gross Profit | $9.0B | $7.1B | $7.8B | $7.9B | $6.8B | $4.6B | $4.4B | $5.2B |
| R&D Expense | $2.1B | $1.9B | $1.7B | $1.6B | $1.5B | $1.3B | $1.2B | $1.2B |
| SG&A Expense | $1.0B | $0.9B | $0.8B | $0.9B | $0.8B | $0.7B | $0.7B | $0.8B |
| Operating Income | $5.9B | $4.3B | $5.2B | $5.4B | $4.5B | $2.7B | $2.5B | $3.2B |
| Net Income | $5.4B | $3.8B | $4.5B | $4.6B | $3.9B | $2.3B | $2.2B | $2.4B |
| EPS (Basic) | $4.17 | $29.13 | $33.30 | $32.92 | $27.22 | $15.55 | $14.37 | $14.73 |
| EPS (Diluted) | $4.15 | $29.00 | $33.21 | $32.75 | $26.90 | $15.10 | $13.70 | $13.17 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.3B | $18.7B | $18.8B | $17.2B | $15.9B | $14.6B | $12.0B | $12.5B |
| Current Assets | $14.5B | $12.9B | $13.2B | $12.3B | $11.7B | $10.9B | $8.6B | $9.1B |
| Cash & Equivalents | $6.4B | $5.8B | $5.3B | $3.5B | $4.4B | $4.9B | $3.7B | $4.5B |
| Total Liabilities | $11.5B | $10.2B | $10.6B | $10.9B | $9.9B | $9.4B | $7.3B | $5.9B |
| Current Liabilities | $6.6B | $4.3B | $4.2B | $4.6B | $3.5B | $3.2B | $2.4B | $3.2B |
| Stockholders' Equity | $9.9B | $8.5B | $8.2B | $6.3B | $6.0B | $5.2B | $4.7B | $6.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.2B | $4.7B | $5.2B | $3.1B | $3.6B | $2.1B | $3.2B | — |
| Investing Cash Flow | $-0.7B | $-0.4B | $-0.5B | $0.6B | $0.1B | $-0.2B | $-1.6B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-4.9B | $-4.0B | $-2.8B | $-4.6B | $-4.2B | $-0.6B | $-2.4B | — |